Buena, NJ - IGI, Inc. said the United States Department of Agriculture's "Stop Sale" order has been lifted for all requested poultry vaccine products made at the company's Vineland Laboratories.
Donald C. Randall, DVM, Director Inspection and Compliance, Center for Veterinary Biologics of the USDA, stated that Vineland Laboratories' new regulatory compliance program was validated during a recent USDA inspection, and he was pleased with the progress that was reported to him. Dr. Randall believes that Vineland Laboratories will be a positive contributor to the poultry industry in the future.
Separately, the company stated that it appreciated the cooperation and guidance that it received from Dr. Randall and Dr. Joan Arnoldi, Deputy Administrator, Veterinary Services, United States Department of Agriculture.
IGI is a diversified company segmented into two business areas: Animal Health, and Skin Care and Consumer Products. The company's Skin Care and Consumer Products business is primarily based on the patented Novasome(R) technology. Licensed from a former subsidiary, the technology offers value-added qualities to cosmetics, skin care products, vaccines, medicines, foods, beverages, and other products.
This press release contains forward-looking statements relating to competitive pressures, general economic conditions, and the risk factors detailed from time to time in IGI's periodic reports and registration statements filed with the Securities and Exchange Commission, including without limitation IGI's Annual Report of Form 10-K for the fiscal year ended December 31, l996.
Press Here for Info on Setting Your Own Web Site
Meat Industry Insights News Service
P.O. Box 553
Northport, NY 11768
Phone: 631-757-4010
Fax: 631-757-4060
E-mail: sflanagan@sprintmail.com
Web Site: http://www.spcnetwork.com/mii